- Home
- JVA vs CRIS Comparison
JVA vs CRIS Comparison
Compare JVA & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JVA
- CRIS
- Stock Information
- Founded
- JVA 1971
- CRIS 2000
- Country
- JVA United States
- CRIS United States
- Employees
- JVA N/A
- CRIS N/A
- Industry
- JVA Packaged Foods
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- JVA Consumer Staples
- CRIS Health Care
- Exchange
- JVA Nasdaq
- CRIS Nasdaq
- Market Cap
- JVA 19.5M
- CRIS 21.3M
- IPO Year
- JVA 2005
- CRIS 2000
- Fundamental
- Price
- JVA $4.18
- CRIS $2.39
- Analyst Decision
- JVA
- CRIS Strong Buy
- Analyst Count
- JVA 0
- CRIS 2
- Target Price
- JVA N/A
- CRIS $16.50
- AVG Volume (30 Days)
- JVA 70.7K
- CRIS 78.6K
- Earning Date
- JVA 06-16-2025
- CRIS 07-31-2025
- Dividend Yield
- JVA N/A
- CRIS N/A
- EPS Growth
- JVA 6252.13
- CRIS N/A
- EPS
- JVA 0.53
- CRIS N/A
- Revenue
- JVA $80,327,181.00
- CRIS $11,202,000.00
- Revenue This Year
- JVA N/A
- CRIS $0.93
- Revenue Next Year
- JVA N/A
- CRIS $8.10
- P/E Ratio
- JVA $8.07
- CRIS N/A
- Revenue Growth
- JVA 15.77
- CRIS 14.17
- 52 Week Low
- JVA $1.23
- CRIS $1.02
- 52 Week High
- JVA $9.93
- CRIS $9.78
- Technical
- Relative Strength Index (RSI)
- JVA 59.89
- CRIS 60.94
- Support Level
- JVA $3.88
- CRIS $2.23
- Resistance Level
- JVA $4.35
- CRIS $2.63
- Average True Range (ATR)
- JVA 0.24
- CRIS 0.18
- MACD
- JVA 0.09
- CRIS 0.03
- Stochastic Oscillator
- JVA 85.04
- CRIS 69.62
About JVA Coffee Holding Co. Inc.
Coffee Holding Co Inc is engaged in wholesale coffee operations, including manufacturing, roasting, packaging, marketing, and distributing roasted and blended coffees for privately labeled accounts and its brands, and it sells green coffee. The Company also manufactures and sells coffee roasters. Its products include wholesale green coffee, private-label coffee, and branded coffee. The company sells its coffee products throughout the United States, Canada, and certain Asian countries. The group's services are Custom Blending, Food Service Programs, and Private Label Services.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.